In silico pharmacology and bioavailability of bioactive constituents from Triclisia subcordata (Oliv), an underutilized medicinal plant in Nigeria
DOI:
https://doi.org/10.14719/pst.2292Keywords:
Triclisia subcordata, Phytochemicals, Pharmacology, ADMET, BioavailabilityAbstract
Medicinal plants are rich sources of traditional medicines from which many modern medicines are made. Triclisia subcordata Oliv. is one among the underutilized medicinal plants in the Southwestern part of Nigeria. Therefore, this study was designed to present comprehensive data from the literature on pharmacological uses of T. subcordata and its phytochemistry, and to predict the pharmacology and bioavailability of the phytoconstituents isolated so far from Triclisia subcordata through an in silico approach. T. subcordata has high antioxidant activity and so it isthus used to treat oxidative stress-related diseases such as inflammation and diabetes. It also has antibacterial, antifungal, antimalarial and smooth muscle relaxing properties. It is a potent inhibitor of enzymes such as alpha-amylase and alpha-glucosidase. It has also traditionally been used in cancer treatment. One of the bisbenzylisoquinoline (BBIQ) alkaloids isolated from this plant, cycleanine, showed selectivity for ovarian cancer cell lines. The presence of phytochemicals such as cyanogenic glycosides and tannins in low concentrations in T. subcordata has also been reported to make it edible to humans. The results of predicted absorption, distribution, metabolism, excretion and toxicity was analyzed on the webserver ’ADEMTLab 2.0‘ . Prediction of activity studies for the four bisbenzylisoquinoline alkaloids isolated so far from this plant supported anticancer, antimicrobial, antidiabetic, antiulcer, antimalarial activities as well as muscle relaxant effect. Moreover, new activities including stimulation of leukopoiesis, inhibition of membrane permeability , inhibition of kinase and nicotinic alpha4beta4 receptor agonist properties were also predicted through in silico investigation. From our findings, these phytoconstituents could be lead candidates in drug discovery, since this plant is safe for human consumption.
Downloads
References
Dar RA, Shahnawaz M, Rasool S, Qazi PH. Natural product medicines: A literature update. J phytopharmacol. 2017;6(6):349-51. www.phytopharmajournal.com/Vol6_Issue6_06.pdf
Aye MM, Aung HT, Sein MM, Armijos C. A review on the phytochemistry, medicinal properties and pharmacological activities of 15 selected Myanmar medicinal plants. Molecules. 2019;24(2):293. https://doi.org/10.3390/molecules24020293
Singh B, Sharma RA. Secondary metabolites of medicinal plants, 4 Volume set: ethnopharmacological properties, biological activity and production strategies. John Wiley & Sons; 2020
Sonibare MA, Adebodun SA. Macroscopic and microscopic evaluation of Triclisia subcordata Oliv.(Menispermaceae) towards its standardization. Nig. J. Pharm. Res. 2018;14 (2):189-96.
Ajugwo AO, Ezimah AC, Awah FM, Mounbegna PE, Azikiwe CC. Phytochemical and antimicrobial properties of the aqueous root extract of Triclisia dictyophylla. Asian J. Med. Sci. 2013;4(1):15-20. https://www.nepjol.info/index.php/AJMS/article/view/7846
Trease G, Evans WC. Pharmacognosy. 11th edn. Brailliar Tiridel. Can. Macmillian.publishers; 1989.
Tiam ER, Ngono Bikobo DS, Abouem A, Zintchem A, Mbabi Nyemeck N, Moni Ndedi ED et al. Secondary metabolites from Triclisia gilletii (De Wild) Staner (Menispermaceae) with antimycobacterial activity against Mycobacterium tuberculosis. Nat. Prod. Res. 2019;33(5):642-50. https://doi.org/10.1080/14786419.2017.1402324
Akinwunmi OA, Adekeye DK, Olagboye SA. Phytochemical quantification, in vitro antioxidant and antidiabetic potentials of methanol and dichloromethane extracts of Triclisia subcordata (Oliv) leaves. TPR. 2020;4(1):17-24.
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7(1):1-13. https://doi.org/10.1038/srep42717
Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z et al. admet SAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics; 2018;35(6):1067-1069. https://doi.org/10.1093/bioinformatics/bty707
Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16(8);747-748. https://doi.org/10.1093/bioinformatics/16.8.747
Gbadamosi IT, Erinoso SM. A review of twenty ethnobotanicals used in the management of breast cancer in Abeokuta, Ogun State, Nigeria. Afr. J. Pharm. Pharmacol. 2016;10(27):546-64. https://doi.org/10.5897/AJPP2015.4327
Ayena AC, Chegnimonhan V, Guidi TC, Adoukonou-Sagbadja H, Karou S, Mensah GA et al. Biodiversity of plants used in the treatment of gastroenteritis in southern Benin. 2016;11(3):145-54.
Uche FI, Abed M, Abdullah MI, Drijfhout FP, McCullagh J, Claridge TW et al. O9 Isolation, identification and anti-cancer activity of minor alkaloids from Triclisia subcordata Oliv. Biochem. Pharmacol. 2017;139:112.
Uche FI, Drijfhout FP, McCullagh J, Richardson A, Li WW. Cytotoxicity effects and apoptosis induction by bisbenzylisoquinoline alkaloids from Triclisia subcordata. Phytother Res. 2016; 30(9):1533-9.
Abo KA, Lawal IO, Ogunkanmi A. Evaluation of extracts of Triclisia suboardata Oliv and Heinsia crinita (Afz) G. Taylor for antimicrobial activity against some clinical bacterial isolates and fungi. Afr. J. Pharm. Pharmacol. 2011;5(2):125-31.
Asuzu IU, Anaga AO. The antiulcer effect of the methanolic extract of Triclisia subcordata leaves in rats. J. Herbs Spices Med. Plants. 1996;3(3):45-53.
Asuzu IU, Okoro UO, Anaga AO. The effects of the methanolic leaf extract of Triclisia subcordata Oliv. on smooth muscles. J. Herbs Spices Med. Plants. 1995;2(4):11-8.
Uche FI, Drijfhout F, McCullagh J, Richardson A, Li WW. In vivo efficacy and metabolism of the antimalarial cycleanine and improved in vitro antiplasmodial activity of novel semisynthetic analogues. Antimicrob Agents Chemother. 2021;65(2-3):1-16
Ali R, Rooman M, Mussarat S, Norin S, Ali S, Adnan M, Khan SN. A systematic review on comparative analysis, toxicology, and pharmacology of medicinal plants against Haemonchus contortus. Front. Pharmacol. 2021; 2:644027..
Abiodun HA, Oluwatobi SA, Joseph AO, Oyetomiwa OF, Kenechukwu BO. Toxicological evaluation of extract of Olax subsorpioidea on albino Wistar rats. Afr. J. Pharm. Pharmacol. 2014; 8(21):570-8.
Agomuo E, Amadi P, Ogunka-Nnoka C, Amadi B, Ifeanacho M, Njoku U. Characterization of oils from Duranta repens leaf and seed. OCL. 2017;24(6):A601.
Okpara FN, Nwaichi EO, Akaninwor JO. Proximate Analysis and Phytochemical Screening of Triclisia subcordata Oliv Leaf. Int. J. Biochem. Res. 2021;30(8): 1-9.
Chanda N, Shukla R, Zambre A, Mekapothula S, Kulkarni RR, Katti K, Bhattacharyya K, Fent GM, Casteel SW, Boote EJ, Viator JA. An effective strategy for the synthesis of biocompatible gold nanoparticles using cinnamon phytochemicals for phantom CT imaging and photoacoustic detection of cancerous cells. Pharm. Res. 2011;28(2):279-91.
Bhattacharya A, Tiwari P, Sahu PK, Kumar S. A review of the phytochemical and pharmacological characteristics of Moringa oleifera. J. Pharm. Bioallied. Sci. 2018;10(4):181.
Yadav RN, Agarwala M. Phytochemical analysis of some medicinal plants. J. Phytol. 2011;3(12): 10-14.
Raies AB., Bajic VB. In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2016;6(2):147-172.
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7: 42717.
Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J. Med. Chem. 2000; 43(21):3867-3877.
Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods. 2000;44(1):235-249. https://doi.org/10.1016/s1056-8719(00)00107-6
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002 45(12):2615-2623.
Hughes JD, Blagg J, Price DA, Bailey S, DeCrescenzo GA, Devraj RV, Ellsworth E, Fobian YM, Gibbs ME, Gilles RW. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg. Med. Chem. Lett. 2008;18(17):4872-4875.
Martin YC. A bioavailability score. J. Med. Chem. 2005;48(9):3164-3170.
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002;45(12):2615-2623.
Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1), W5-W14.
Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics. Clin. Pharmacokinet. 2003; 42(1), 59-98.
Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, Fontanella MM. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020;162(7):1491-4.
Raschi E, Vasina V, Poluzzi E, De Ponti F. The hERG K+ channel: target and antitarget strategies in drug development. Pharmacol. Res. 2008; 57(3):181-195.
Kratz JM, Grienke U, Scheel O, Mann SA, Rollinger JM. Natural products modulating the hERG channel: heartaches and hope. Nat. Prod. Rep. 2017;34(8), 957-980.
Am B. D-isochondodendrine in the treatment of dysmenorrhea. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise. 1951;3(1):63-4.
Otshudi AL, Apers S, Pieters L, Claeys M, Pannecouque C, De Clercq E, Van Zeebroeck A, Lauwers S, Frederich M, Foriers A. Biologically active bisbenzylisoquinoline alkaloids from the root bark of Epinetrum villosum. J. Ethnopharmacol. 2005;102(1):89-94.
Uche FI, Guo X, Okokon J, Ullah I, Horrocks P, Boateng, J et al. In vivo efficacy and metabolism of the antimalarial cycleanine and improved in vitro antiplasmodial activity of novel semisynthetic analogues. Antimicrob. Agents Chemother. 2021; 65(2):e01995-20
Bhagya N, Chandrashekar KR. Tetrandrine–A molecule of wide bioactivity. Phytochemistry. 2016;125:5-13.
Bhagya NC, Chandrashekar KR. Tetrandrine and cancer–An overview on the molecular approach. Biomed. Pharmacother. 2018;97:624-32.
Wambebe C, Gamaniel K, Akah PA, Kapu SD, Samson A, Orisadipe AT et al. Central and uterotonic effects of cycleanine. Indian J. Pharmacol. 1997;29(5):366.
Sonavane GS, Palekar RC, Kasture VS, Kasture SB. Anticonvulsant and behavioural actions of Myristica fragrans seeds. Indian J. Pharmacol. 2002;34(5):332.
Li W. Cytotoxicity effects and apoptosis induction by cycleanine and tetrandrine. Planta Med.: Natural Products and Medicinal Plant Research. 2016;30(9):1533-9.
Downloads
Published
Versions
- 01-07-2023 (2)
- 20-04-2023 (1)
How to Cite
Issue
Section
License
Copyright (c) 2022 Akingbolabo Daniel Ogunlakin, Taiwo Rukayat Onifade, Gideon Ampoma Gyebi, Blessing Ariyo Obafemi, Oluwafemi Adeleke Ojo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright and Licence details of published articles
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Open Access Policy
Plant Science Today is an open access journal. There is no registration required to read any article. All published articles are distributed under the terms of the Creative Commons Attribution License (CC Attribution 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
